| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_61f88efcda59d7062a4252ecf6886f58 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-315 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1132 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 |
| filingDate |
1993-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_763c1008cf96135e0f841fa53b503acd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ca51e6dc1a528c03fdaf13b1e2a106d |
| publicationDate |
1995-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0649466-A1 |
| titleOfInvention |
Method of inhibiting viral replication |
| abstract |
The present invention relates to a method for selecting drugs suitable for use in inhibiting viral replication in vivo. The invention also relates to a method of inhibiting viral replication that involves the use of oligonucleotides complementary to specific regions of the genome of the target virus. |
| priorityDate |
1992-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |